Latest News Feed
Innovative medical technologies like the sam® device promote soft tissue healing
Sustained Acoustic Medicine developer avoids supply chain tangles to supply healthcare providers with needed medical intervention.
New research demonstrates how sustained acoustic medicine (SAM) accelerates healing and recovery from soft tissue injury common in college and professional sports
Innovative, wearable, FDA-cleared long-duration ultrasound device proven effective in rehabilitation and pain management, medical journal review reports.
Dr. George Lewis, inventor of sam® soft tissue healing pain relief ultrasound device, to review 2022 clinical research on technology and patient outcomes
Cutting-edge sustained acoustic medicine soft tissue healing treatment developed in partnership with federal research support will now help federal workers recover from injury and improve surgery outcomes.
Wearable ultrasound sam® device heals soft tissue injuries faster, reduces need for surgery and pain medications.
Groundbreaking ultrasound therapy company helps the Whale and other sports teams recover, manage pain and stay in the game
Sustained acoustic medicine (sam®) device for soft tissue injuries is available for patients and healthcare providers to amplify the body's natural ability to heal by increasing local circulation
Wearable ultrasound technology from ZetrOZ Systems meets patients' need for for drug-free, non-invasive treatment extending healing to the home
Wearable ultrasound therapy for home use assists in healing and reduces reliance on narcotic pain medications, which only mask pain
The pain management ultrasound device helps heal injuries and return employees back to work without surgery or narcotics.
ZetrOZ's Sustained Acoustic Medicine (samⓇ) backed by 15 years of research, 30 clinical studies, 300,000 patients
The wearable sustained acoustic medicine (sam®) device has been leveraged by athletes to help treat injuries sustained during competition
The FDA-cleared home-use ultrasound device will be featured at the world's largest gathering of orthopaedic surgeons
SAMⓇ, the only FDA-cleared, wearable home ultrasound device will display its healing functions at the world's largest event for chiropractic medicine.
As industry ramps up to pre-pandemic levels, the pain management ultrasound device helps employers and workers minimize effects of workplace injury
ZetrOZ Systems' long-duration ultrasound device provides new options for orthopedic surgeons
American-made products mean more transparency and higher standards, resulting in a better overall product and customer experience.
Company achieves first and only FDA-approved, wearable device for multi-hour continuous ultrasound therapy for home-use.
Dr. George Lewis of ZetrOZ Systems to present results of large clinical trial at Special Operations Medical Association's annual Scientific Assembly
ZetrOZ Systems partners with Dr. Rod Walters, nationally recognized sports medicine clinical educator, for an upcoming course on soft-tissue regeneration and rapid response care.
Retired Army Ranger tells how ZetrOZ Systems' Sustained Acoustic Medicine (SAM) device has helped him rehab from injuries
Structures in the healthcare system often stifle innovation and breakthrough treatments.
ZetrOZ partners with many women's sports organizations to promote Sustained Acoustic Medicine (SAM) as a treatment for various forms of chronic and acute pain.
Dr. George Lewis outlines benefits and effectiveness of novel technology for non-invasive, non-opioid pain relief
The bill aims to expand provider access to FDA-approved, non-opioid pain management approaches. Sustained Acoustic Medicine, developed by ZetrOZ Systems, is among those approaches.
New study finds vast majority of athletic trainers confident in value of sustained acoustic medicine technology
ZetrOZ and the NIA aim to develop new pain-relieving innovations and help make them available to the public faster.
Review finds ZetrOZ technology also lowers treatment costs significantly improving care for the aging patient population
Spring training means Baseball season is almost underway after an early ending last season due to the pandemic.
sam® wearable ultrasound device has helped career law enforcement officers injured in the line of duty reduce chronic pain and get their lives back.
ZetrOZ is expanding the utilization of Sustained Acoustic Medicine to help 100 million people with soft-tissue injuries and chronic pain
Sustained Acoustic Medicine (SAM) is now part of the majority of university curriculum for Athletic Training, Physical Therapy, and Occupational Therapy students, as well as pre-med students learning about mechanobiology.
Super Bowl-caliber NFL teams and elite athletic organizations reveal the healing benefits of SAM technology.
Those on government insurance — veterans, state and federal employees — have access to coverage for SAM technology.
ZetrOZ is expanding on the certified SAM CME Education Program, offering multiple CME courses across several delivery platforms with Dr. Rod Walters and Dr. Rajiv Mallipudi.
SAM technology is growing more popular among professional athletes and everyday people for its ability to reduce pain and help recover without invasive surgery. Drug-free and safe.
Sustained acoustic medicine (SAM) technology, approved by the FDA in 2013 for clinical utilization, sees re-approval for expanded indications in 2020.
A 2020 real-world outcomes research study finds athletes utilizing sustained acoustic medicine (SAM) experience average pain decrease, improvement in function and quality of life, and faster return to sport.
A growing number of sports organizations are raving about the healing potential of Sustained Acoustic Medicine (SAM), its impact on recovery times, and how it's helping athletes get back in the game after injury.
ZetrOZ is partnering with the National Women's Hockey League, becoming the official sustained acoustic medical device of the Connecticut Whale
ZetrOZ earns a place on the 2020 Inaugural List of Most Innovative Companies in Healthcare, a list compiled by former Secretary of Veterans Health Administration, Dr. David Shulkin, M.D.
Wearable SAM ultrasound treatment is shown to be a cost-effective solution for the treatment of knee arthritis pain, compared to physical therapy and hyaluronic acid injections.
SAM's ability to restore grip strength due to complications from elbow tendinosis — sometimes known as tennis elbow — has drawn attention from amateur tennis clubs and communities around the U.S.
New research shows SAM medical technology can deliver nonsteroidal, anti-inflammatory drugs (NSAIDs) locally and more effectively than existing technologies in the treatment of arthritis.
Sustained Acoustic Medicine (SAM) is helping athletes across sports of all levels — college, minors, pros, and even Olympians — recover from muscular injuries without surgery and be back on the field within weeks. Watch the story: https://www.youtube.com/watch?v=rGXZw1Bke0E&t
sam® technology is the number one prescribed ultrasound device in the professional sports industry.
